Pharvaris (PHVS) Accumulated Expenses (2019 - 2026)

Pharvaris (PHVS) has 8 years of Accumulated Expenses data on file, last reported at $22.3 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses changed N/A year-over-year to $22.3 million; the trailing twelve-month figure through Mar 2026 stood at $22.3 million (changed N/A YoY), and the FY2025 full-year result was $26.4 million, up 38.57% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $22.3 million, down from $27.2 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $27.2 million in Q4 2025 and bottomed at $11.1 million in Q4 2022.
• The 5-year median for Accumulated Expenses is $18.8 million (2024), against an average of $18.3 million.
• The widest annual swing landed in 2022, when Accumulated Expenses jumped 127.46%; it then climbed 7.17% in 2023.
• A 5-year view of Accumulated Expenses shows it stood at $11.1 million in 2022, then advanced by 7.17% to $11.9 million in 2023, then jumped by 57.83% to $18.8 million in 2024, then jumped by 44.61% to $27.2 million in 2025, then fell by 17.96% to $22.3 million in 2026.
• The last three Accumulated Expenses figures came in at $22.3 million (Q1 2026), $27.2 million (Q4 2025), and $18.8 million (Q4 2024), per Business Quant data.

Peer Comparison